United Capital Financial Advisors’s Accelerate Diagnostics AXDX Stock Holding History

United Capital Financial Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,223	Closed	-$281K	–	1287
2018 Q3	$281K	Hold	1,223	–	–	﹤0.01%	1132
2018 Q2	$273K	Hold	1,223	–	–	﹤0.01%	1119
2018 Q1	$279K	Sell	1,223 -107	-8%	-$28.1K	﹤0.01%	1118
2017 Q4	$348K	Hold	1,330	–	–	﹤0.01%	1067
2017 Q3	$298K	Buy	1,330 +228	+21%	+$56K	﹤0.01%	1114
2017 Q2	$301K	Buy	1,102 +30	+3%	+$8.13K	﹤0.01%	1070
2017 Q1	$259K	Hold	1,072	–	–	﹤0.01%	1095
2016 Q4	$222K	Hold	1,072	–	–	﹤0.01%	1144
2016 Q3	$292K	Hold	1,072	–	–	﹤0.01%	1082
2016 Q2	$150K	Hold	1,072	–	–	﹤0.01%	1199
2016 Q1	$154K	Buy	+1,072	New	+$151K	﹤0.01%	1154

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

United Capital Financial Advisors's AXDX Position: Q4 2018 in Review

United Capital Financial Advisors sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 1,223 shares — an estimated $281K sold.

United Capital Financial Advisors first reported a position in AXDX in Q1 2016 and held it in 11 quarters. The position peaked at $348K in Q4 2017. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

United Capital Financial Advisors reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
United Capital Financial Advisors sold 1,223 Accelerate Diagnostics shares in Q4 2018, an estimated $281K.
United Capital Financial Advisors first reported a position in Accelerate Diagnostics in Q1 2016 and held it in 11 quarters.
United Capital Financial Advisors's Accelerate Diagnostics position peaked at $348K in Q4 2017.
107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on United Capital Financial Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.